首页 | 本学科首页   官方微博 | 高级检索  
     


Persistent Neonatal Thyrotoxicosis in a Neonate Secondary to a Rare Thyroid-Stimulating Hormone Receptor Activating Mutation:
Affiliation:1. Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, People''s Republic of China;2. Department of Obstetrics and Gynecology, The First Affiliated Hospital of Luzhou Medical College, Luzhou 626000, People''s Republic of China;1. Department of Radiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran;2. Department of Radiology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran;3. Department of Pediatric Endocrinology and Metabolism, Mofid Children''s Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran;4. Pediatric Infections Research Center, Research Institute for Children''s Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran;5. Pediatric Congenital Hematologic Disorders Research Center, Research Institute for Childern Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract:ObjectiveTo report the case of a neonate presenting with nonautoimmune thyrotoxicosis and failure to thrive in whom an activating TSHR mutation was suspected.MethodsWe describe the clinical and laboratory findings in a neonate who presented with nonautoimmune thyrotoxicosis and failure to thrive, including results of DNA analysis of TSHR, which encodes the thyroid-stimulating hormone receptor (TSHR). Relevant literature is also reviewed.ResultsThe proband was born spontaneously at 35 weeks’ gestation, and his early neonatal period was remarkable for meconium aspiration, pneumothorax, hepatomegaly with associated elevated transaminases, and direct hyperbilirubinemia. On days 9 and 11 of life, thyroid function studies revealed hyperthyroidism, which remained persistent on day 26 of life. On day 44 of life, the infant was admitted to the hospital. The mother reported he had an increased activity level, disturbed sleep, jitteriness, and exaggerated startle response. Weight was at the third percentile. After additional workup, Lugol’s iodine solution, propanolol, and propylthiouracil were prescribed, which led to improvement in thyroid function. No TSHR antibodies were detected in the mother’s or patient’s sera. Analysis of the patient’s DNA revealed a heterozygous T-to-C substitution at amino acid 568 in exon 10 (Ile568Thr), which predicts an isoleucine to threonine conversion in the second extracellular loop of TSHR. The mutation was not identified in the parents’ DNA.ConclusionsA mutation causing constitutive activation of TSHR was confirmed in this patient, a finding that has implications for genetic counseling and consideration of total thyroidectomy or long-term thionamide therapy followed by radioiodide ablation as treatment options. Although rare, TSHR mutations should be considered in an infant presenting with thyrotoxicosis in absence of demonstrable TSHR antibodies in serum. (Endocr Pract. 2008;14:479-483)
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号